The recombinant subunit vaccine RBD-Fc, consisting of SARS-CoV-2 RBD and human IgG Fc as an immunopotentiator, elicits robust neutralizing antibody responses against SARS-CoV-2 infectionZezhong Liu, Shibo Jiang, Shuai Xia et al.|Research Square|2020Cited by 2